Published in:
01-04-2012 | Research
Down-Regulated Expression of HSP70 in Correlation with Clinicopathology of Cholangiocarcinoma
Authors:
Sirintip Boonjaraspinyo, Thidarut Boonmars, Sasithorn Kaewkes, Porntip Laummaunwai, Somchai Pinlaor, Watchalin Loilome, Puangrat Yongvanit, Zhiliang Wu, Anucha Puapairoj, Vajarabhongsa Bhudhisawasdi
Published in:
Pathology & Oncology Research
|
Issue 2/2012
Login to get access
Abstract
Cholangiocarcinoma is a crucial health problem in northeast Thailand. Although rare, it is a highly fatal disease and the prognosis of CCA patients is very poor. To determine if expression of specific genes is useful for diagnosis and prognosis for CCA. We examined the expression of HSP70, HSP90, RB1, cyclin D1, and HDAC6 in 50 resections of human CCA tissues by quantitative real-time PCR. The expression of HSP70, RB1, and HDAC6 was “dominant down-regulation,” while the expression of cyclin D1 and HSP90 was “dominant up-regulation.” There were no correlations between RB1, cyclin D1, HSP90, and clinicopathological parameters such as status, histology type, histological grading, stage of CCA, and metastasis. A significant association was found between HDAC6 and CCA staging (p = 0.000), CCA gross type and HSP70 (p = 0.046) as well as RB1 expression (p = 0.046). Patients with down-regulation of HSP70 had significantly poorer prognosis than those in the up-regulation group (p = 0.002). Expression of HSP70 may be useful as a new prognostic marker for CCA.